MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$104,937K
(-9.84%↓ Y/Y)
Cash and cash
equivalents
$6,152K
(-27.59%↓ Y/Y)
Prepaid expenses and
other current assets
$2,485K
(-12.41%↓ Y/Y)
Total current assets
$113,574K
(-11.07%↓ Y/Y)
In-process research and
development
$32,386K
(0.00%↑ Y/Y)
Operating lease asset, net
$530K
(-37.65%↓ Y/Y)
Other assets
$177K
(-50.00%↓ Y/Y)
Total assets
$146,667K
(-9.08%↓ Y/Y)
Total liabilities,
convertible preferred stock...
$146,667K
(-9.08%↓ Y/Y)
Convertible preferred
stock, value-Series...
$53,543K
(0.00%↑ Y/Y)
Total liabilities
$46,209K
(-1.11%↓ Y/Y)
Total stockholders
equity
$44,764K
(-23.98%↓ Y/Y)
Convertible preferred
stock, value-Series...
$2,151K
(0.00%↑ Y/Y)
Accumulated deficit
-$440,228K
(-21.58%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$72K
(-300.00%↓ Y/Y)
Warrant liabilities
$30,378K
(-12.72%↓ Y/Y)
Total current
liabilities
$13,458K
(46.52%↑ Y/Y)
Deferred tax liabilities
$2,187K
(0.18%↑ Y/Y)
Non-current operating lease
liabilities
$186K
(-66.49%↓ Y/Y)
Additional paid-in capital
$484,988K
(15.22%↑ Y/Y)
Common stock, 0.001 par
value, 300,000,000...
$76K
(26.67%↑ Y/Y)
Accounts payable
$6,585K
(126.99%↑ Y/Y)
Accrued expenses and
other liabilities
$6,504K
(9.15%↑ Y/Y)
Current operating lease
liabilities
$369K
(13.54%↑ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
Eledon Pharmaceuticals, Inc. (ELDN)
Eledon Pharmaceuticals, Inc. (ELDN)